PERSPECTA

News from every angle

← Back to headlines

Biohaven and Yale Win $4 Million Judgment in Trade Secret Misappropriation Case

A federal court has entered a judgment confirming that RA Capital and Avilar Therapeutics willfully and maliciously misappropriated a trade secret developed at Yale, formalizing a $4 million award to Biohaven and Yale University.

25 Aug, 20:41 — 25 Aug, 20:41
PostShare

Sources

Showing 1 of 2 sources
morningstar20h ago

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University - Morningstar

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University  Morningstar

Read full article →

Coverage Timeline

First report: morningstar · 25 Aug, 20:41Full coverage: 2 · 7mWindow: 7m
Left-leaningCenterRight-leaning
morningstar25 Aug, 20:41First to report

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University - Morningstar

investing-com25 Aug, 20:48Latest update

Biohaven, Yale win $4M judgment in trade secret case

Related Stories

IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures

16m ago

Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance

32m ago

TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe

36m ago

Montenegro Official Rejects Alleged Political Pressure Attempts

38m ago